RankingsPricing
  1. US-listed companies
  2. LIGAND PHARMACEUTICALS INC
  3. Raw

LIGAND PHARMACEUTICALS INC【LGND】

Market cap
$4B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents71212160971921117724820452372
Short-term investments10-47103122181601940364322167147184
Accounts receivable, net--------305785303338
Inventory1210224772627132414
Income taxes receivable--------1126564
Prepaid expenses------------12
Other current assets1112222205453317
Total current assets3224251852161632378711,124501465264237332
Intangible assets, net5756535148205229220210595551342300267
Goodwill151212121272868795190181106103105
Financial Royalty Assets, Non Current-------------185
Noncurrent derivative assets-------------11
Property and equipment, net0110024571421121615
Operating lease right-of-use assets--------107171167
Finance lease right-of-use assets---------1616433
Equity Method Investments----3086-----13-
Other investments------------3611
Deferred income taxes, net------8447262434900
Other assets11000250243567
Total assets1221041052585346026711,2611,4951,3621,298763787942
Accounts payable116484324248525
Accrued liabilities855556719101918161228
Income tax payable-------------1
Deferred revenue-------322911011
Current contingent liabilities7027105563403000
Current operating lease liabilities---------22101
Current finance lease liabilities---------70000
Total current liabilities4435292321227239821710042991737
Long-term deferred revenue-------------2
Long-term contingent liabilities11111283397698333
Long-term operating lease liabilities--------106151066
Deferred income taxes, net--------336559313233
Other long-term liabilities01110111223131222830
Total liabilities105785523423023125270072865347616586111
Common Stock, Value, Issued00000000000000
Additional paid-in capital733752718681701770798791367318373148199337
Accumulated other comprehensive loss--35532-1-0-1-1-1-1-6
Retained earnings-682-683-671-659-402-431-401-229400392449451503499
Total stockholders’ equity-265026304341400561767710821597701830
Total liabilities and stockholders’ equity1221041052585346026711,2611,4951,3621,298763787942